DUB:UPR - Euronext Dublin - IE00BJ5FQX74 - Common Stock - Currency: EUR
DUB:UPR (3/7/2025, 7:00:00 PM)
2.71
+0.01 (+0.37%)
The current stock price of UPR.I is 2.71 EUR. In the past month the price increased by 11.52%. In the past year, price decreased by -2.69%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
AMP.MI | AMPLIFON SPA | 30.68 | 4.72B | ||
FAGR.BR | FAGRON | 17.45 | 1.35B | ||
ILM1.DE | MEDIOS AG | 25.09 | 339.28M | ||
BLC.PA | BASTIDE LE CONFORT MEDICAL | N/A | 184.37M | ||
TLIK.DE | ARZNEIWERK AG VIDA | N/A | 3.03M |
Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. The company is headquartered in Dublin, Dublin and currently employs 3,262 full-time employees. The company went IPO on 2019-07-17. The firm is focused on improving access to pharmaco-medical products and therapies. The company operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through its on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare and animal health products to pharmacies, hospitals and veterinary surgeons in Ireland. The company operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. The company also provides services and support that help independent community pharmacies.
UNIPHAR PLC
4045 Kingswood Drive, Citywest Business Park
DUBLIN DUBLIN IE
Employees: 3000
Company Website: https://www.uniphar.ie/
Investor Relations: http://www.uniphar.ie/static/investors/investor-overview/
Phone: 35314287777
The current stock price of UPR.I is 2.71 EUR. The price increased by 0.37% in the last trading session.
The exchange symbol of UNIPHAR PLC is UPR and it is listed on the Euronext Dublin exchange.
UPR.I stock is listed on the Euronext Dublin exchange.
10 analysts have analysed UPR.I and the average price target is 4.63 EUR. This implies a price increase of 70.7% is expected in the next year compared to the current price of 2.71. Check the UNIPHAR PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
UNIPHAR PLC (UPR.I) has a market capitalization of 703.60M EUR. This makes UPR.I a Small Cap stock.
UNIPHAR PLC (UPR.I) currently has 3000 employees.
UNIPHAR PLC (UPR.I) has a support level at 2.57 and a resistance level at 2.72. Check the full technical report for a detailed analysis of UPR.I support and resistance levels.
The Revenue of UNIPHAR PLC (UPR.I) is expected to grow by 8.94% in the next year. Check the estimates tab for more information on the UPR.I EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
UNIPHAR PLC (UPR.I) has a dividend yield of 0.87%. The yearly dividend amount is currently 0.02. Check the full fundamental report for a detailed analysis of UPR.I dividend history, reliability and sustainability.
UNIPHAR PLC (UPR.I) will report earnings on 2025-09-01.
The PE ratio for UNIPHAR PLC (UPR.I) is 15.94. This is based on the reported non-GAAP earnings per share of 0.17 and the current share price of 2.71 EUR. Check the full fundamental report for a full analysis of the valuation metrics for UPR.I.
ChartMill assigns a technical rating of 8 / 10 to UPR.I. When comparing the yearly performance of all stocks, UPR.I turns out to be only a medium performer in the overall market: it outperformed 65.66% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to UPR.I. While UPR.I is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months UPR.I reported a non-GAAP Earnings per Share(EPS) of 0.17. The EPS increased by 1.35% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.68% | ||
ROA | 3.18% | ||
ROE | 12.9% | ||
Debt/Equity | 1.14 |
ChartMill assigns a Buy % Consensus number of 82% to UPR.I. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 8.13% and a revenue growth 8.94% for UPR.I